Table 1.
Demographic and clinical characteristics of control and HD subjects.
Fig 1.
Mean blood glucose levels at different time points during a glucose tolerance test in controls, premanifest and moderate HD patients and the corresponding mean insulin (A), growth hormone (B) and cortisol (C) concentrations.
Table 2.
Fasting levels of metabolic markers in control, premanifest and stage II/III HD cohorts.
Data are presented as Mean ±SD for normally distributed data and as median [minimum—maximum] for skewed data.
Table 3.
Levels of amino acids (μmol/L) in control, premanifest and stage II/III HD cohorts as determined by ion exchange chromatography and reversed-phase HPLC. Data are presented as Mean (SD).